and non-oral administration of Ac-Nle-cyc7o(-Asp-His-D-Phe-Arg-Trp-Lys)-OH (PT-141)
What GLP-1 Medications Actually Do in the Body GLP-1 receptor agonists like semaglutide and tirzepatide work primarily by mimicking a gut hormone that regulates appetite and blood sugar
PMID: 23 FernsG
GLP-1 is a hormone released by intestinal L-cells that regulates hunger, satiety, blood sugar control, digestion speed, and metabolic balance
Patients must be at least 18 years old and meet one of the following clinical requirements when GLP-1 therapy begins: A body mass index, or BMI, of 35 or higher A BMI between 30 and 34.99 with at least one qualifying health condition A BMI between 27 and 29.99 with at least one qualifying higher-risk health condition For someone with a BMI between 30 and 34.99, qualifying conditions may include heart failure with preserved ejection fraction, uncontrolled high blood pressure, stage 3a or higher chronic kidney disease, prediabetes, a previous heart attack or stroke, or symptomatic peripheral artery disease